Increased levels of surgical adhesions in TGFβ1 heterozygous mice

Journal of Investigative Surgery

Volumn 12, Issue 1, 1999, Pages 31-38

  Krause, Tyrone J ^a   Katz, Dan ^a,d   Wheeler, Cathrine J ^b   Ebner, Sylvie ^b   McKinnon, Randall D ^b,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d NONE   (United States)

Author keywords

ELISA analysis; Surgical adhesions; Transforming growth factor 1; Transgenic mice

Indexed keywords

MAGNESIUM SILICATE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HETEROZYGOSITY; MOUSE; NONHUMAN; PERITONEAL FLUID; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0033022406     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/089419399272746     Document Type: Article

References (39)

1. Gabbay S, Guindy AM, Andrews JF, Amato JJ, Seaver P, Khan MY. New outlook on pericardial substitution after open heart operations. Ann Thorac Surg. 1989;48: 803-812.
2. Bunton RW, Xabregas AA, Miller AP. Pericardial closure after cardiac operations. An animal study to assess currently available materials with particular reference to their suitability for use after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;100:99-107.
3. Eng J, Ravichandran PS, Abbott CR, Kay PH, Murday AJ, Shreiti I. Reoperation after pericardial closure with bovine pericardium. Ann Thorac Surg. 1989;48:813-815.
4. Ivarsson ML, Holmdahl L, Franzen G, Risberg B. Cost of bowel obstruction resulting from adhesions. Eur J Surg. 1997;163:679-684.
5. Holmdahl L, Risberg B. Adhesions: Prevention and complications in general surgery. Eur J Surg. 1997;163:169-174.
6. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, diZerega GS, Ellis H. Adhesions: Pathogenesis and prevention - Panel discussion and summary. Eur J Surg Suppl. 1997;577:56-62.
7. Heydorn WH, Daniel JS, Wade CE. A new look at pericardial substitutes. J Thorac Cardiovasc Surg. 1987;94:291-296.
8. Vander Salm TJ, Okike ON, Marsicano TH, Compton C, Espinoza E. Prevention of postoperative pericardial adhesions. An animal study. Arch Surg. 1986;121:462-467.
9. Revuelta JM, Garcia-Rinaldi R, Val F, Crego R, Duran CM. Expanded polytetrafluoroethylene surgical membrane for pericardial closure. An experimental study. J Thorac Cardiovasc Surg. 1985;89:451-455.
10. Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat. 1973; 115:375-392.
11. Raftery AT. An enzyme histochemical study of mesothelial cells in rodents. J Anat. 1973;115:365-373.
12. Strange C, Tomlinson JR, Wilson C, Harley R, Miller KS, Sahn SA. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol. Pathol. 1989;51:205-219.
13. Diamond MP, DeCherney AH. Pathogenesis of adhesion formation/reformation: Application to reproductive pelvic surgery. Microsurgery. 1987;8:103-107.
14. Gervin AS, Jacobs G, Hufnagel HV, Mason KG. Surgical trauma and pericardial fibrinolytic activity. Am Surg. 1975;41:225-229.
15. Nkere UU, Whawell SA, Sarraf CE, Schofield JB, Thompson JN, Taylor KM. Perioperative histologic and ultrastrurtural changes in the pericardium and adhesions. Ann Thorac Surg. 1994;58:437-444.
16. Mitchell JD, Lee R, Hodakowski GT, Neya K, Harringer W, Valeri CR, Vlahakes GJ. Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solution. Experimental safety and efficacy studies. J Thorac Cardiovasc Surg. 1994;107:1481-1488.
17. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
18. Kaidi AA, Gurchumelidze T, Nazzal M, Figert P, Vanterpool C, Silva Y. Tumor-necrosis factor-alpha: A marker for peritoneal adhesion formation. J Surg Res. 1995;58:516-518.
19. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann NY Acad Sci. 1990;580:225-232.
20. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl. 1997;577:17-23.
21. Miller DA, Pelton RW, Derynck R, Moses HL. Transforming growth factor-beta. A family of growth regulatory peptides. Ann NY Acad Sci. 1990;593:208-217.
22. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res. 1992;52:65-70.
23. Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta 1. J Surg Res. 1996;65:135-138.
24. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.
25. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimai hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
26. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Yu, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 1992;360:361-364.
27. Chegini N, Gold LI, Williams RS. Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced endometriosis in the rat. Obstet Gynecol. 1994;83:455-461.
28. Sporn MB, Roberts AB, Shull JH, Smith JM, Ward JM, Sodek J. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science. 1983;219:1329-1331.
29. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
30. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770-774.
31. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, McCartney-Francis NL, Furcht LT, Karlsson S, Wahl SM. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci USA. 1994;91:5187-5191.
32. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 1994;264:1936-1938.
33. Boivin GP, Molina JR, Ormsby I, Stemmermann G, Doetschman T. Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab Invest. 1996;74:513-518.
34. Krause TJ, Zazanis GA, McKinnon RD. Prevention of post-operative adhesions with the chitin derivative N, O-carboxymethyl chitosan. Wound Repair Regenerat. 1996;4:53-57.
35. Krause TJ, Goldsmith NK, Ebner S, Zazanis GA, McKinnon RD. An inhibitor of cell proliferation associated with adhesion formation is supressed by N-O-carboxymethyl chitosan. J Invest Surg. 1998;11:105-113.
36. McKinnon RD, Piras G, Ida JA, Jr., Dubois-Dalcq M. A role for TGF-beta in oligodendrocyte differentiation. J Cell Biol. 1993;121:1397-1407.
37. Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci USA. 1993;90:9944-9948.
38. Young RL, Cota J, Zund G, Mason BA, Wheeler JM. The use of an amniotic membrane graft to prevent postoperative adhesions. Fertil Steril. 1991;55:624-628.
39. Saba AA, Kaidi AA, Godziachvili V, Dombi GW, Dawe EJ, Libcke JH, Silva YJ. Effects of interleukin-6 and its neutralizing antibodies on peritoneal adhesion formation and wound healing. Am Surg. 1996;62:569-572.